For both sides
What is Schedule III medical marijuana?
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- As of 28 April 2026, marijuana under a state medical license (and FDA-approved products) is Schedule III. Adult-use is not.
- Verify with counsel.
- State rules differ.
- Book a call if this is a live file.
What is Schedule III medical marijuana is the file this page underwrites. As of 28 April 2026, marijuana under a state medical license (and FDA-approved products) is Schedule III. Adult-use is not. Federal and state law current as of September 2026 — verify with counsel.
Direct answer to “What is Schedule III medical marijuana?”?
As of 28 April 2026, marijuana under a state medical license (and FDA-approved products) is Schedule III. Adult-use is not. That is the working answer as of September 2026. It is not a guarantee of price, timing, approval, or financing.
Why “What is Schedule III medical marijuana?” is the wrong first question?
Start with transferability and eligibility. What is Schedule III medical marijuana? is downstream. A Massachusetts owner and a Washington owner will not share an answer even if sales match.
| Question behind “What is Schedule III medical marijuana?” | Where to read next |
|---|---|
| Can the paper move? | Transfer rules |
| What is cash after tax? | 280E |
| Who may own it? | Eligibility |
| What is it worth? | Valuation |
A Massachusetts example on “What is Schedule III medical marijuana?”?
Illustrative only: the Massachusetts fact pattern does not price a Washington shop. Bring the license type to the intro call.
Cited sources that govern What is Schedule III medical marijuana?: FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026.
Treat What is Schedule III medical marijuana? as a state-license file with a federal tax and banking overlay. Schedule III medical relief is real for qualifying activity and irrelevant to an adult-use-only book. Hemp SKUs face CRS IN12620 on the 2026 hemp definition on 12 November 2026. Do not import a 2021 multiple onto that fact pattern.
Related pages for What is Schedule III medical marijuana?
Read transfers next if that file is open on What is Schedule III medical marijuana?. contact is the companion page when What is Schedule III medical marijuana? needs that angle. Keep FAQ index in the working set for What is Schedule III medical marijuana?. Read sell next if that file is open on What is Schedule III medical marijuana?. buy is the companion page when What is Schedule III medical marijuana? needs that angle. Keep valuation in the working set for What is Schedule III medical marijuana?. Read federal law next if that file is open on What is Schedule III medical marijuana?. 280E is the companion page when What is Schedule III medical marijuana? needs that angle.
Which public sources belong on this file?
Cite USCIS Policy Manual, U.S. Treasury, DEA drug scheduling, DEA diversion schedules. A forum post is not a substitute.
How should you underwrite What is Schedule III medical marijuana?
What is Schedule III medical marijuana has to haircut as a license-and-tax file. In Arizona, scarcity can dominate. In Oregon, paper value can be near zero. Cited sources that govern What is Schedule III medical marijuana: SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E.
| Check | Arizona | Oregon |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
What does a 280E-literate CPA ask?
What is Schedule III medical marijuana has to clear as a license-and-tax file. In Massachusetts, scarcity can dominate. In Washington, paper value can be near zero. Cited sources that govern What is Schedule III medical marijuana: SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order.
| Check | Massachusetts | Washington |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
What is Schedule III medical marijuana?
As of 28 April 2026, marijuana under a state medical license (and FDA-approved products) is Schedule III. Adult-use is not.
How does the November 2026 hemp clock matter?
P.L. 119-37 and [CRS IN12620 on the 2026 hemp definition](https://www.congress.gov/crs-product/IN12620) reset the definition on 12 November 2026. If this question includes intoxicating hemp, underwrite the post-rule catalog.
What multiple should you not use?
A 2021 MSO slide, a liquor-store rule, or a national slogan. Commentary 3x–6x is a conversation, not an appraisal of this question.
When should you walk away?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026. Optimism does not repair this question.
How should the sale stay confidential?
Use a blind teaser and an NDA. Employees and landlords learn on a planned day. This question is not a Facebook post.
What capital actually funds these deals?
Seller paper, private credit, cash, or a sale-leaseback. SBA will not appear. [SAFE Banking Act of 2026, S.4942](https://www.congress.gov/bill/119th-congress/senate-bill/4942) is not a close condition for this question.
Sources
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- USCIS Policy Manual — https://www.uscis.gov/policy-manual
- U.S. Treasury — https://home.treasury.gov/
- DEA drug scheduling — https://www.dea.gov/drug-information/drug-scheduling